Christin Zuendorf
Chief Business Officer,
TQ Therapeutics
Christin’s expertise is in the field of commercial strategy and organization design and spent over 8 years in strategic consulting within the pharmaceutical and life science industry as well as in the field of venture building. Her deep knowledge in commercial strategy and venture building contributes to shaping the future of biotech endeavors, ultimately benefiting patients, and advancing healthcare.
Sessions
-
11-Feb-2026Innovation ZoneTQ Therapeutics: CELLfinity – Hybrid in vivo CGT for scalable patient access